Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Benefits of Low Dosage of Colchicine Administration on Decreasing Rehospitalization and Mortality within 30 Days in Post-Acute Coronary Syndrome Patients with ST-Segment Elevation Undergoing Percutaneous Coronary Intervention

Heart Science Journal · Vol. 4 No. 3 (2023) · hlm. 28–33

DOI
10.21776/ub.hsj.2023.004.03.6
ISSN
2721-9984, 2721-9976
Terbit
2023-07-01
Penerbit
Universitas Brawijaya
Bahasa
en

Abstrak

Background: The role of inflammation in myocardial infarction and post-infarction MI remodeling has become a concern for the development of treatment in the last decade. Colchicine can prevent increased inflammation during acute injury.Objective: This study focused on the role of colchicine as an on-top medical treatment, hoping it can reduce mortality and short-term rehospitalization in patients with STEMI.Methods: 347 AMI patients (18-80 year old adults) who visited RSUD dr. Saiful Anwar Malang, between February 2022 and January 2023, participated in this prospective, randomized, double-blinded, placebo-controlledexperiment. Patients were split into two groups and given either a placebo or colchicine 0.5 mg daily for a month. Standard medical therapy was administered concurrently to both groups as an approachable guideline. The study endpoints were mortality and rehospitalization rates.Result: After one month of follow-up, there was a reduction in rehospitalization due to cardiovascular causes (2 [1.3%] vs. 4 [2.7%], HR 3.42 [1.36-8.56], p 0,05). In the treated group, there was also a lower non-cardiovascular rehospitalization rate compared to placebo, but not significant (4 [2.6%] vs. 7 [4.7], HR 0.42 [0.15-1.02], p<0.05).Conclusion: The administration of low-dose colchicine for one month has shown benefits in reducing rehospitalization in patients with STEMI who receive PCI therapy.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 300 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Indra PrasetyaUniversity of Brawijaya47
Anna Fuji RahimahUniversity of Brawijaya40
Novi KurnianingsihUniversity of Brawijaya35
Ardian RizalUniversity of Brawijaya34
Djanggan SargowoUniversity of Brawijaya29
Sasmojo WiditoUniversity of Brawijaya29
Heny MartiniUniversity of Brawijaya23
Yoga WaranugrahaUniversity of Brawijaya16
Muhammad Rizki FadlanUniversity of Brawijaya11
Valerinna YogibuanaAfiliasi tidak diketahui9
Anna Fuji RahimahAfiliasi tidak diketahui7
Valerinna Yogibuana Swastika PutriUniversity of Brawijaya7
Adhika Prastya WikanandaUniversity of Brawijaya6
Tri AstiawatiUniversity of Brawijaya6
Putri Annisa KamilaUniversity of Brawijaya6
Dadang HendrawanUniversity of Brawijaya6
Wella KarolinaUniversity of Brawijaya6
Ayu Asri Devi AdityawatiUniversity of Brawijaya6
Saskia Dyah HandariUniversity of Brawijaya5
Imelda KrisnasariUniversity of Brawijaya5
Teguh AryanugrahaUniversity of Brawijaya5
Ira Vori NugrohoUniversity of Brawijaya5
Fandy HazzyUniversity of Brawijaya4
Hayla Iqda MillisaniUniversity of Brawijaya4
Fahmy RusnantaUniversity of Brawijaya4
Ratna PancasariUniversity of Brawijaya4
Krishna Ari NugrahaUniversity of Brawijaya4
Seprian WidasmaraUniversity of Brawijaya4
Evit RuspionoAfiliasi tidak diketahui4
Shalahuddin Suryo BaskoroUniversity of Brawijaya4
Lutfi Hafiz ZunardiUniversity of Brawijaya4
Oktivani Adelathifa RahmaUniversity of Brawijaya3
Nikhen NoverikeUniversity of Brawijaya3
Yuri AfifahUniversity of Brawijaya3
Zhafran VeliawanUniversity of Brawijaya3

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Benefits of Low Dosage of Colchicine Administration on Decreasing Rehospitalization and Mortality within 30 Days in Post-Acute Coronary Syndrome Patients with ST-Segment Elevation Undergoing Percutaneous Coronary Intervention</dc:title>
	<dc:creator xml:lang="en">Satrijo, Budi</dc:creator>
	<dc:creator xml:lang="en">Ashari, Yordan Wicaksono</dc:creator>
	<dc:creator xml:lang="en">Rohman, Mohammad Saifur</dc:creator>
	<dc:creator xml:lang="en">Anjarwani, Setyasih</dc:creator>
	<dc:creator xml:lang="en">Tjahjono, Cholid Tri</dc:creator>
	<dc:subject xml:lang="en">ST Elevation Myocardial Infarction</dc:subject>
	<dc:subject xml:lang="en">Colchicine</dc:subject>
	<dc:subject xml:lang="en">Percutaneus Coronary Intervention</dc:subject>
	<dc:description xml:lang="en">Background: The role of inflammation in myocardial infarction and post-infarction MI remodeling has become a concern for the development of treatment in the last decade. Colchicine can prevent increased inflammation during acute injury.Objective: This study focused on the role of colchicine as an on-top medical treatment, hoping it can reduce mortality and short-term rehospitalization in patients with STEMI.Methods: 347 AMI patients (18-80 year old adults) who visited RSUD dr. Saiful Anwar Malang, between February 2022 and January 2023, participated in this prospective, randomized, double-blinded, placebo-controlledexperiment. Patients were split into two groups and given either a placebo or  colchicine 0.5 mg daily for a month. Standard medical therapy was administered concurrently to both groups as an approachable guideline. The study endpoints were mortality and rehospitalization rates.Result: After one month of follow-up, there was a reduction in rehospitalization due to cardiovascular causes (2 [1.3%] vs. 4 [2.7%], HR 3.42 [1.36-8.56], p&amp;lt;0.05), which was significant in the treatment group compared to the control group. Also, there was a reduction in all-cause mortality, but not statistically significant (2 [1,3% v 3 [2,0%], HR 3,38 [0,53-7,48], p&amp;gt;0,05). In the treated group, there was also a lower non-cardiovascular rehospitalization rate compared to placebo, but not significant (4 [2.6%] vs. 7 [4.7], HR 0.42 [0.15-1.02], p&amp;lt;0.05).Conclusion: The administration of low-dose colchicine for one month has shown benefits in reducing rehospitalization in patients with STEMI who receive PCI therapy.</dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2023-07-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/13095</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2023.004.03.6</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 4 No. 3 (2023): The Essensial Role of the Metabolic Syndrome in the Development of Cardiovascular Disease; 28-33</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2023.004.03</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/13095/351</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2023 Budi Satrijo, Yordan Wicaksono Ashari, Mohammad Saifur Rohman, Setyasih Anjarwani, Cholid Tri Tjahjono</dc:rights>
</oai_dc:dc>